CID 135404978

Sildenafil metabolite (uk-331,849) (m2)

Structural Information

Molecular Formula
C19H26N6O4S
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCN)OCC)C
InChI
InChI=1S/C19H26N6O4S/c1-4-6-14-16-17(25(3)24-14)19(26)23-18(22-16)13-11-12(7-8-15(13)29-5-2)30(27,28)21-10-9-20/h7-8,11,21H,4-6,9-10,20H2,1-3H3,(H,22,23,26)
InChIKey
REQLDLBZEIDOHX-UHFFFAOYSA-N
Compound name
N-(2-aminoethyl)-4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

434.1736 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 435.18088 204.4
[M+Na]+ 457.16282 214.4
[M-H]- 433.16632 206.7
[M+NH4]+ 452.20742 211.2
[M+K]+ 473.13676 207.3
[M+H-H2O]+ 417.17086 195.5
[M+HCOO]- 479.17180 218.1
[M+CH3COO]- 493.18745 230.2
[M+Na-2H]- 455.14827 206.0
[M]+ 434.17305 211.4
[M]- 434.17415 211.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.